Happy Family Medicine: Prescriptions That Told Pharmacies Not to Check

Happy Family Medicine’s physician-owner, an Antelope Valley doctor, entered a guilty plea on October 16, 2023, in a telemedicine case involving controlled substances obtained by fraud and the distribution of oxycodone. The Justice Department’s account of the criminal case describes false patient identities, prescriptions issued without proper medical evaluations and drugs resold on the black market. The person writing the prescriptions skipped identity checks, then told the people filling them not to check either.

What Happened at Happy Family Medicine?

Happy Family Medicine advertised a clinic in a Hollywood co-working space. The Justice Department’s criminal case account describes a practice that operated primarily by telephone and text. Its owner was a California physician authorized by the Drug Enforcement Administration to prescribe medication during the conduct described by the Justice Department, from at least December 2019 through August 2021.

In its criminal case account, the department described prescriptions issued without full medical histories, physical examinations, medical testing or diagnostic tools. The physician also failed to verify customers’ identities and allowed them to obtain prescriptions in other people’s names.

What Are Some Examples of Prescription Fraud?

Prescriptions issued in false names and supported by invented addresses and dates of birth are concrete examples from the Happy Family Medicine criminal case. The Justice Department reported that the physician worked with two co-conspirators who supplied those false details. He issued the prescriptions, and the co-conspirators filled them and resold the drugs on the black market. The department also reported prescriptions for people the physician knew were fictitious.

Pharmacy Notes That Discouraged Verification

The Justice Department reported that many fraudulent prescriptions carried notes, either on the prescription or in accompanying documents, falsely urging pharmacies not to verify them. The stated reason was urgent medical need. The notes claimed that failing to dispense could be life threatening because of the COVID-19 pandemic.

The appeal to patient safety did the work of discouraging a safety check. A pharmacist received a prescription carrying a physician’s authority, accompanied by a reason to avoid questioning it. For an insider, the accompanying message matters as much as the drug name or the signature.

The department also reported hundreds of false prescriptions for liquid promethazine with codeine, including prescriptions for fictitious patients, totaling more than 82 liters. The physician directed them to pharmacies across the country for co-conspirators to obtain.

That national distribution makes the practice’s own communications especially useful. Each pharmacy would encounter the orders directed to it. The prescribing side connected the identities, the repeated orders and the directions about verification across pharmacy destinations. The case’s scale sits in that repeated process, as well as in the amount prescribed.

What the Undercover Transactions Showed

The Justice Department’s criminal case account describes repeated prescribing to undercover officers without proper medical evaluations or identity verification. It says the prescriptions fell outside professional practice and lacked a legitimate medical purpose.

From April through July 2020, the physician prescribed one undercover officer 702 oxycodone pills of ten milligrams each and 240 milliliters of promethazine with codeine. From May through July of that year, he prescribed another undercover officer 234 Norco pills containing a total of 2,340 milligrams of hydrocodone, along with 180 alprazolam pills. Alprazolam is sold under the brand name Xanax.

These were repeated transactions over several months. The department’s account ties each group of prescriptions to a buyer whose identity and clinical needs the physician had not properly checked.

The original criminal indictment likewise charged individual distributions by drug and date. Its allegations included oxycodone, hydrocodone, alprazolam, and promethazine with codeine.

Remote Prescribing Still Depends on the Encounter

The emergency prescribing exceptions began in March 2020, during the period covered by this case. They allowed qualifying prescribing without a prior in-person evaluation while retaining the requirement for a legitimate medical purpose. That puts the pharmacy notes in focus: invoking a pandemic emergency did not supply the missing patient history or establish why a particular person needed the medication. Done offers a platform example: the Justice Department’s account of the criminal trial evidence described its clinical president prescribing stimulants to members he had never evaluated and whose records he had not reviewed.

Who Investigates Prescription Fraud?

The Drug Enforcement Administration investigated the Happy Family Medicine case, with substantial assistance from the California Department of Justice’s Bureau of Medi-Cal Fraud and Elder Abuse. The U.S. Attorney’s Office for the Central District of California prosecuted it.

The undercover encounters connected what the physician did with what he prescribed. An employee’s view can connect different parts of that same process: the source of patient details, messages about the requested medication, the clinical note, the signed prescription and communications with the dispensing pharmacy.

When Prescription Records Connect to False Claims

Pharmacy billing can bring remote prescriptions into a False Claims Act case. In a separate matter, Healthy Meds Pharmacy agreed to a settlement over alleged fraudulent claims to TRICARE. That case concerned prescriptions under TRICARE’s telemedicine policy and the pharmacy’s claims for payment.

For an insider whose information also involves government health care payments, the prescribing records and billing records belong in the same conversation. They connect the patient, the order, the business that submitted the claim and the government program asked to pay. Our whistleblower experts assess those connections with you. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Saw What Reached the Pharmacy

If you saw invented patient details, prescriptions issued without review or messages telling pharmacies to skip verification, speak with our whistleblower experts. We pair your knowledge of the prescription records and any false government claims with healthcare fraud whistleblower lawyers experienced in remote prescribing. From the first review through the case, you have our experts working beside you.